Navigation Links
Better Treatment for obesity

A little-known fatty compound produced in the small intestine could hold the key to permanent weight loss. Oleylethanolamide (OEA) is a type of fatty acid that is produced in the small intestine in response to food. This compound, oleylethanolamide (OEA), could lead to the development of better treatments for eating disorders and obesity. //

The effects of OEA are striking and profoundly different from those of traditional appetite suppressants. This implies that molecular mimics of OEA, or synthetic molecules that resemble OEA but are more potent and more resistant to degradation by the body, could be used in the treatment of obesity and overweight.

The study shows that when injected into the bodies of rats, OEA caused the rats to eat significantly less food and gain weight at a slower pace. Studies are now under way to investigate how OEA works on a cellular and molecular level, and to determine whether OEA has appetite-suppressing effects in humans, the researcher noted.


'"/>




Page: 1

Related medicine news :

1. Better prostate cancer detection
2. For a Better Memory
3. Baby Talk Better Than Adult Speech
4. Drug Combo Works Better for children with ADHD, Tics
5. Better skin with lasers
6. Better diabetes treatment promises Vanadium
7. Better Prostate Cancer Test
8. Better Drug for Heart Transplant
9. Better Diet Even Late in Life May Prolong It
10. Better Care Required for Breast Cancer Survivors
11. Two drugs Mays Be Better Than One For Prostate Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Better Treatment for obesity

(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...ernet archive for research works on medical and al...nt body, has been nominated as a finalist for the ...cked by the National Informatics Centre, OpenMED a...archive their scientific and technical documents. ...
...e visit off Hurricane Katrina, the survivors are s...d on the survivors scattered across the nation // ...hat the people are now facing problems, and suffer...the federal government has launched the biggest & ...
... Ohio-based Cleveland Clinic, to inaugrate a satel...ices which would benefit Canadians // considering ...t. The Cleveland clinic houses more than 1,900 sci... medical group in the U.S, treating pateints from ...
...markets Aricept with Pfizer Inc. Aricept is alread...te Alzheimer's disease //, but at present it was b...e second most common form of dementia after Alzhei...s show that about eleven patients have died while ...
Other Medicine News:Health News:OpenMED Nominated For Stockholm Challenge 2006 Award 2Health News:Hurricane Hangover: Katrina Still Haunts 2Health News:Hurricane Hangover: Katrina Still Haunts 3Health News:Hurricane Hangover: Katrina Still Haunts 4Health News:Satellite Clinic To Be Set Up in Toronto By Ohio-Based Cleveland Clinic 2
(Date:8/19/2008)...IEGO, Aug. 19 /- Vical Inco...ch collaboration with the Karolinska,Institute, a ...sh Institute,for Infectious Disease Control (SMI),... Vaxfectin(R) adjuvant with the Biojector(R) 2000,...nologies Inc.,OTCBB:BJCT) for a multivalent preve...
(Date:8/18/2008)...ALEM, Israel, August 18 /- ...tp://www.oramed.com ), a developer,of oral deliver...tled "Open,Label Study to Assess the Safety, Pharm... Oral Insulin Formulations in Healthy,Subjects," h...th Annual,Meeting of the European Association for ...
(Date:8/17/2008)...Y, Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall...unced that the first pivotal Phase 3,clinical tria...is has,completed enrolment., The first efficacy d...ing the first half of 2009. The trial commenced it...recruitment target of 250 subjects in June,2008 an...
(Date:8/14/2008)... cell engaging antibody (BiTE) showing clinical be...ients own T cells to recognize and attack ... Aug. 14 /- Micromet, Inc.,...loping novel, proprietary,antibodies for the treat...es, today announced publication of a Phase 1 clini...
Breaking Medicine Technology:Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 2Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 3Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 4Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 5Clinical Data Published in 'Science' Show Tumor Regressions in Relapsed Lymphoma Patients Treated with T Cell Engaging BiTE Antibody Blinatumomab 6Gynecologic Oncologist With Board Certification in GYN Oncology OB GYN and Surgery Offers Women With Cancer the Newest Treatment Frontier 3A the Su 4449 1Gynecologic Oncologist With Board Certification in GYN Oncology OB GYN and Surgery Offers Women With Cancer the Newest Treatment Frontier 3A the Su 4449 2Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 1Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 2Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 3Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 4Navigenics Proposes Standards for Personal Genomics Services Coupled With Prospective Outcomes Studies to Safeguard Consumers 16205 5Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision 4447 1How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 1How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 2How Patients Can Meet the Criteria for Insulin Pump Therapy 16199 3
...swire/ -- At the April AACR,Annual Meeting, Indivu...c basis for a new drug test-platform to predict dr...imary cell lines are currently the first,choice fo...on and,expansion, however, their gene and protein ...losing many of their primary,characteristics. Prim...
... Biogen Idec (NASDAQ: BIIB),and Elan Corporation, ... the TOUCH Prescribing Program(TM) and TYGRIS safe...clinical studies of,TYSABRI(R) (natalizumab). Also...can Academy of Neurology in Boston, MA were extens...ained treatment,effect on clinical relapses and th...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 2Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 3Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 4Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 5Data Presented at the American Academy of Neurology's Annual,Meeting Provide Update on Utilization and Safety of Tysabri in,Patients with Multiple Sclerosis 6
...n Through A 1.0mm Incision., ,Special Direct A...Ergonomics., ,Curved Shafts For A More Comfort...b-Incisional Flap Purchase., ,Protective Cap S...n., ,Reusable, Autoclaveable, Guaranteed For L...
The blades are actually bent to form a concave posterior surface. The result is a blade which better conforms to incising a globe at a non-perpendicular angle. The resulting incision is more pristine
...Design With Spreading Spatula Tips That Mimic Corn...g & Lifting Of Corneal Flaps Created With The Intr...ips Of The Forceps Are Designed To Facilitate Acce...d, The Cross-Action Forceps Design Allows The Surg...
...ut Foldable Silicone Lenses Through A Smaller Inci...en High Diopter Silicone Lenses With Ease With One...ertion Through A 2.6mm Phaco Incision For Explanta...ay Surgical Evaluation Without Obligation, & A Com...
Medicine Products: